CRT 2026
Endovascular
Mohammad M. Ansari, MD
Assistant Professor/ Cath Lab Director
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Disclosure(s): No financial relationships to disclose
Jihad A. Mustapha, MD, FACC, FSCAI
Interventional Cardiologist
Lorven Heart & Vascular Institute
Ada, Michigan, United States
Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)
Eric J. Dippel, MD
Interventional Cardiologist
Vascular Institute of the Midwest, PC
Bettendorf, Iowa, United States
Disclosure information not submitted.
James Stephen Jenkins, MD
Section Head, Interventional Cardiology
Director, Interventional Cardiology Research
Ochsner Medical Center
New Orleans, Louisiana, United States
Disclosure(s): Abbott Vascular: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Aravinda Nanjundappa, MD, FSCAI
Director of Peripheral Vascular Interventions, Cardiovascular Division
Cleveland Clinic , Main Campus
Pepper pike, Ohio, United States
Disclosure(s): No financial relationships to disclose
Timir Paul, MD, PhD, FACC, FSCAI
Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States
Disclosure(s): No financial relationships to disclose
Thomas Zeller, MD
Director Department Angiology
Universitäts-Herzzentrum Freiburg - Bad Krozingen, University Clinic Freiburg, Germany
Bad Krozingen, Baden-Wurttemberg, Germany
Disclosure(s): No financial relationships to disclose